MOLECULAR INSIGHTS INTO THE REPLICATION AND PATHOGENESIS OF HEPATITIS C VIRUS
Main Article Content
Abstract
Hepatitis C virus (HCV) is a major infectious disease problem worldwide, resulting in serious liver disease, including cirrhosis and hepatocellular carcinoma. This review article acts as a general overview of molecular aspects of HCV replication and pathogenesis emphasizing the virus structure and genome, entry mechanisms, the replication cycle, and HCV interactions with the host immune system. It also examines the progression of disease causing HCV infections and the clinical symptoms. Antiviral treatments have improved patient outcomes, but they remain far from an effective vaccine, because viral diversity, lack of access to health care, remain. Research in the future should look to increase healthcare accessibility, to understand long term outcomes after treatment, and to develop the vaccine. Solution to these challenges will enable us to diminish the worldwide burden of HCV and better patient health results.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Irshad M, Gupta P, Irshad K. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World J Hepatol. 2017;9(36):1305-14.
Vescovo T, Refolo G, Vitagliano G, Fimia GM, Piacentini M. Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. Clinical Microbiology and Infection. 2016;22(10):853-61.
Goto K, Roca Suarez AA, Wrensch F, Baumert TF, Lupberger J. Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip. Int J Mol Sci. 2020;21(9).
Dustin LB, Bartolini B, Capobianchi MR, Pistello M. Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy. Clin Microbiol Infect. 2016;22(10):826-32.
Ashfaq UA, Javed T, Rehman S, Nawaz Z, Riazuddin S. An overview of HCV molecular biology, replication and immune responses. Virology Journal. 2011;8(1):161.
Lavie M, Goffard A, Dubuisson J. HCV glycoproteins: assembly of a functional E1–E2 heterodimer. Hepatitis C viruses: Genomes and molecular biology. 2006.
Tong Y, Lavillette D, Li Q, Zhong J. Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly. Front Immunol. 2018;9:1411.
Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev. 2020;33(2).
Topi S, Gaxhja E, Charitos IA, Colella M, Santacroce L. Hepatitis C Virus: History and Current Knowledge. Gastroenterology Insights. 2024;15(3):676-707.
Shi ST, Lai MM. HCV 5′ and 3′ UTR: when translation meets replication. Hepatitis C Viruses: genomes and molecular biology. 2006.
Pan CQ, Zhang JX. Natural History and Clinical Consequences of Hepatitis B Virus Infection. Int J Med Sci. 2005;2(1):36-40.
Tabata K, Neufeldt CJ, Bartenschlager R. Hepatitis C Virus Replication. Cold Spring Harb Perspect Med. 2020;10(3).
Shi G, Suzuki T. Molecular Basis of Encapsidation of Hepatitis C Virus Genome. Frontiers in Microbiology. 2018;9.
Koch JO, Bartenschlager R. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B. J Virol. 1999;73(9):7138-46.
Gawlik K, Gallay PA. HCV core protein and virus assembly: what we know without structures. Immunol Res. 2014;60(1):1-10.
Ng WC, Soto-Acosta R, Bradrick SS, Garcia-Blanco MA, Ooi EE. The 5' and 3' Untranslated Regions of the Flaviviral Genome. Viruses. 2017;9(6).
Nagy PD, Pogany J. The dependence of viral RNA replication on co-opted host factors. Nat Rev Microbiol. 2011;10(2):137-49.
Ploss A, Evans MJ. Hepatitis C virus host cell entry. Curr Opin Virol. 2012;2(1):14-9.
Zeisel MB, Barth H, Schuster C, Baumert TF. Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy. Front Biosci (Landmark Ed). 2009;14(9):3274-85.
Cohen S, Au S, Panté N. How viruses access the nucleus. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2011;1813(9):1634-45.
Rampersad S, Tennant P. Replication and Expression Strategies of Viruses: Viruses. 2018:55-82. doi: 10.1016/B978-0-12-811257-1.00003-6. Epub 2018 Mar 30.
Ferreira AR, Ramos B, Nunes A, Ribeiro D. Hepatitis C Virus: Evading the Intracellular Innate Immunity. J Clin Med. 2020;9(3).
Svitkin YV, Pause A, Lopez-Lastra M, Perreault S, Sonenberg N. Complete translation of the hepatitis C virus genome in vitro: membranes play a critical role in the maturation of all virus proteins except for NS3. J Virol. 2005;79(11):6868-81.
Miller S, Krijnse-Locker J. Modification of intracellular membrane structures for virus replication. Nat Rev Microbiol. 2008;6(5):363-74.
Romero-Brey I, Merz A, Chiramel A, Lee JY, Chlanda P, Haselman U, et al. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog. 2012;8(12):e1003056.
Ranjith-Kumar C, Kao CC. Biochemical activities of the HCV NS5B RNA-dependent RNA polymerase. Hepatitis C viruses: genomes and molecular biology. 2006.
Nomaguchi M, Ackermann M, Yon C, You S, Padmanabhan R. De novo synthesis of negative-strand RNA by Dengue virus RNA-dependent RNA polymerase in vitro: nucleotide, primer, and template parameters. J Virol. 2003;77(16):8831-42.
Herker E, Ott M. Unique ties between hepatitis C virus replication and intracellular lipids. Trends Endocrinol Metab. 2011;22(6):241-8.
Lindenbach BD. Virion assembly and release. Curr Top Microbiol Immunol. 2013;369:199-218.
Fiehn F, Beisel C, Binder M. Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals. Current Opinion in Virology. 2024;67:101423.
Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RT. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol. 2014;61(1 Suppl):S79-90.
Preciado MV, Valva P, Escobar-Gutierrez A, Rahal P, Ruiz-Tovar K, Yamasaki L, et al. Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy. World J Gastroenterol. 2014;20(43):15992-6013.
Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019;8(4).
Georgel P, Schuster C, Zeisel MB, Stoll-Keller F, Berg T, Bahram S, et al. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. Trends Mol Med. 2010;16(6):277-86.
Quirino A, Marascio N, Branda F, Ciccozzi A, Romano C, Locci C, et al. Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies. Pathogens. 2024;13(9):766.
Sun J, Rajsbaum R, Yi M. Immune and non-immune responses to hepatitis C virus infection. World J Gastroenterol. 2015;21(38):10739-48.
Dustin LB. Innate and Adaptive Immune Responses in Chronic HCV Infection. Curr Drug Targets. 2017;18(7):826-43.
Obaid A, Naz A, Ikram A, Awan FM, Raza A, Ahmad J, et al. Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy. Scientific Reports. 2018;8(1):8874.